DOCSLIB.ORG

The Role of the Key Effector of Necroptotic Cell Death, MLKL, in Mouse Models of Disease

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Role of the Key Effector of Necroptotic Cell Death, MLKL, in Mouse Models of Disease biomolecules Review The Role of the Key Effector of Necroptotic Cell Death, MLKL, in Mouse Models of Disease Emma C. Tovey Crutchfield 1,2,3 , Sarah E. Garnish 2,3 and Joanne M. Hildebrand 2,3,* 1 Department of Medical Education, University of Melbourne, Parkville, VIC 3052, Australia; [email protected] 2 The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; [email protected] 3 Department of Medical Biology, University of Melbourne, Parkville, VIC 3052, Australia * Correspondence: [email protected] Abstract: Necroptosis is an inflammatory form of lytic programmed cell death that is thought to have evolved to defend against pathogens. Genetic deletion of the terminal effector protein—MLKL— shows no overt phenotype in the C57BL/6 mouse strain under conventional laboratory housing conditions. Small molecules that inhibit necroptosis by targeting the kinase activity of RIPK1, one of the main upstream conduits to MLKL activation, have shown promise in several murine models of non-infectious disease and in phase II human clinical trials. This has triggered in excess of one billion dollars (USD) in investment into the emerging class of necroptosis blocking drugs, and the potential utility of targeting the terminal effector is being closely scrutinised. Here we review murine models of disease, both genetic deletion and mutation, that investigate the role of MLKL. We summarize a series of examples from several broad disease categories including ischemia reperfusion injury, Citation: Tovey Crutchfield, E.C.; sterile inflammation, pathogen infection and hematological stress. Elucidating MLKL’s contribution Garnish, S.E.; Hildebrand, J.M. The to mouse models of disease is an important first step to identify human indications that stand to Role of the Key Effector of Necroptotic Cell Death, MLKL, in benefit most from MLKL-targeted drug therapies. Mouse Models of Disease. Biomolecules 2021, 11, 803. https:// Keywords: necroptosis; MLKL; programmed cell death doi.org/10.3390/biom11060803 Academic Editors: Ivan Poon, Georgia Atkin-Smith, Rochelle Tixeira 1. Introduction and Amy A. Baxter Necroptosis and Disease Mixed Lineage Kinase Domain-Like (MLKL) was shown to be the essential effector of a Received: 1 May 2021 pro-inflammatory, lytic form of programmed cell death called necroptosis in 2012 [1,2]. Like Accepted: 24 May 2021 other forms of lytic cell death (e.g., pyroptosis), necroptosis is characterised by the release Published: 28 May 2021 of Damage-Associated Molecular Patterns (DAMPs) and IL-33, IL-1α and IL-1β production, as recently reviewed by [3]. Unlike apoptosis, necroptosis and the canonical signalling Publisher’s Note: MDPI stays neutral pathway RIPK1-RIPK3-MLKL are not essential to the development and homeostasis of with regard to jurisdictional claims in multicellular organisms [4]. The two most downstream effectors of necroptosis, MLKL and published maps and institutional affil- iations. its obligate activating kinase RIPK3, can be deleted at the genetic level in laboratory mice without any overt developmental consequences in the absence of challenge [5–7]. Thus, it is widely held that MLKL and necroptosis have evolved primarily to defend against pathogenic insult to cells and tissues. This important role of necroptosis in pathogen defence is written in the DNA of many bacteria and viruses alike, which together encode Copyright: © 2021 by the authors. several genes that disarm different facets of the necroptotic signalling pathway [8–10]. Licensee MDPI, Basel, Switzerland. In evolution, genetic deletion of MLKL and/or RIPK3 in the ancestors of modern day This article is an open access article carnivora, metatheria (marsupials) and aves (birds) show that complex vertebrates can distributed under the terms and conditions of the Creative Commons survive without necroptosis when faced with infectious challenges of the ‘real world’ [11]. Attribution (CC BY) license (https:// This adds to the precedent for the well-honed flexibility, redundancy and co-operation creativecommons.org/licenses/by/ of different programmed cell death pathways in the defence against pathogens [12] and 4.0/). offers some biological guide that inhibiting MLKL pharmacologically in humans would not Biomolecules 2021, 11, 803. https://doi.org/10.3390/biom11060803 https://www.mdpi.com/journal/biomolecules Biomolecules 2021, 11, 803 2 of 21 Biomolecules 2021, 11, 803 2 of 22 [12] and offers some biological guide that inhibiting MLKL pharmacologically in humans would not compromise pathogenic defence. Interestingly, recent studies suggest that the suppression of necroptosis may even reduce the resulting inflammatory response that is oftencompromise more dangerous pathogenic than defence. the infection Interestingly, itself [13]. recent Mlkl studies gene suggest knockout that (abbreviated the suppression to bothof necroptosis Mlkl−/− and Mlkl may KO) even mice reduce are distinguishable the resulting inflammatory from wild-type response mice in that numerous is often mod- more −/− elsdangerous of disease, than a broad the infection sampling itself of which [13]. Mlkl are genepresented knockout (Table (abbreviated 1) and illustrated to both (FigureMlkl 1)and here.Mlkl KO) mice are distinguishable from wild-type mice in numerous models of disease, a broadThe therapeutic sampling of potential which are for presented necroptosis-targ (Table1)eted and drugs illustrated lies largely (Figure in1 non-infectious) here. indications.The therapeutic The first human potential clinical for necroptosis-targeted trials of RIPK1-targetted drugs small lies largely molecule in non-infectious compounds wereindications. conducted The in first cohorts human of rheumatoid clinical trials arthri of RIPK1-targettedtis, ulcerative colitis small and molecule psoriasis compounds patients [14].were While conducted these showed in cohorts some of promise rheumatoid in phase arthritis, II, these ulcerative were returned colitis and to the psoriasis research pa- tients [14]. While these showed some promise in phase II, these were returned to the phase in late 2019 by their licensee GlaxoSmithKline [15]. At the time of writing, there are research phase in late 2019 by their licensee GlaxoSmithKline [15]. At the time of writing, only three active clinical trials in progress: a phase I trial assessing the safety of a new there are only three active clinical trials in progress: a phase I trial assessing the safety RIPK1 inhibitor (GFH312), a phase II study utilising RIPK1-binding compound, of a new RIPK1 inhibitor (GFH312), a phase II study utilising RIPK1-binding compound, SAR443122, in cutaneous lupus erythematosus patients and a phase I/II study utilising SAR443122, in cutaneous lupus erythematosus patients and a phase I/II study utilising RIPK1 inhibitor GSK2982772 in psoriasis [16]. There are currently no ‘first in human’ trials RIPK1 inhibitor GSK2982772 in psoriasis [16]. There are currently no ‘first in human’ trials of RIPK3- or MLKL-binding compounds listed on http://clinicaltrials.gov (accessed on 28 of RIPK3- or MLKL-binding compounds listed on http://clinicaltrials.gov (accessed on May 21). 28 May 2021). Neurological Sciatic nerve injury Focal cortical ischemia Autoimmune encephalomyelitis CPZ-demyelination Salivary glands Parkinson’s disease Focal inflammation1 Hematological Musculoskeletal Casp8-/- & Fadd-/- Acute muscle injury lymphadenopathy & autoimmunity 1 MYC-KO Arthritis (A20 ) Lymphoproliferative disease1 Prolonged bleeding time VTE Hematopoietic defects 1 Cardiac remodelling, Hepatic IAV convalescence IRI Respiratory Asymptomatic S.pneumoniae S.marcescens1 IAV, lethal dose1 Renal Secondary S.pneumoniae to IAV Cholesterol crystal embolism IRI1 AKI (sodium oxalate) AKI (cisplatin driven) 1 ANCA vasculitis Gastrointestinal L.monocytogenes 1 Acute colitis (DSS) 1 S.enterica Metabolic Colitis, ileitis Diet-induced obesity 1 (FaddIEC-KO, Casp8IEC-KO, Tsc1IEC-KO, cFLIPs)1 Atherosclerosis Pancreatitis (cerulein) 1 NAFLD (high fat) NAFLD (FFC diet)1 Systemic inflammation Casp8D387A/D387A S.aureus sepsis1 TNFα, high dose1 Skin SHARPIN deficiency Subcutaneous S.aureus Lethal neonatal Inflammation (Ripk1EKO)1 inflammatory syndrome (MlklD139V)1 Necroptosis protects against disease. Necroptosis contributes to disease. FigureFigure 1. 1. TheThe role role of of necroptosis necroptosis in in infective infective and and non-in non-infectivefective challenges challenges spanning spanning a awide wide array array of of 1 physiologicalphysiological systems. systems. Littermate1 Littermate controls controls utilised. utilised. Biomolecules 2021, 11, 803 3 of 22 Table 1. Understanding the role of necroptosis in the aetiology of disease using Mlkl−/− and mutant mice. −/− −/− Challenge Method Outcome in Mlkl (Mutant or Knock-Down) Mouse Relative to Mlkl Mouse and Wild-Type Control Reference Wild-Type Control Details Ischemia and reperfusion injury (IRI) −/− Reduced TUNEL positive hepatocytes and serum ALT levels in Mlkl −/− Hepatic IRI 45 min ischemia in chow mice, irrespective of diet. Hepatic neutrophil infiltration and TNF, IL-1, Sex-matched Mlkl (CRISPR-Cas9) and [17] or Western diet fed mice. Wt mice utilised. MIP-2, and IL-6 mRNA reduced post I/R in Mlkl−/− mice. −/− Renal Cholesterol crystal Mlkl mice protected from infarction (measured by infarct size, kidney infarction, no −/− [18] embolism. injury and neutrophil infiltration). No difference in the extent of acute Mlkl [5] and Wt mice utilised. reperfusion kidney injury (measured by eGFR) and kidney
Load more

Recommended publications
  • The Potential Role of Necroptosis in Clinical Diseases (Review)
    INTERNATIONAL JOURNAL OF MOleCular meDICine 47: 89, 2021 The potential role of necroptosis in clinical diseases (Review) WENLI DAI1*, JIN CHENG1*, XI LENG2, XIAOQING HU1 and YINGFANG AO1 1Institute of Sports Medicine, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing 100191; 2Medical Imaging Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510405, P.R. China Received November 19, 2020; Accepted March 8, 2021 DOI: 10.3892/ijmm.2021.4922 Abstract. As an important type of programmed cell death in 1. Introduction addition to apoptosis, necroptosis occurs in a variety of patho‑ physiological processes, including infections, liver diseases, Necroptosis, an emerging field closely related to apoptosis, is a kidney injury, neurodegenerative diseases, cardiovascular non‑caspase‑dependent cell death that has been implicated in diseases, and human tumors. It can be triggered by a variety the pathological processes of various diseases. It is regulated of factors, such as tumor necrosis factor receptor and Toll‑like by various genes that cause regular and ordered cell death. receptor families, intracellular DNA and RNA sensors, and Through activating specific death signaling pathways, it shares interferon, and is mainly mediated by receptor‑interacting typical characteristics of necrosis, including loss of metabolic protein kinase 1 (RIP1), RIP3, and mixed lineage kinase function and subcellular changes (1,2). Receptor‑interacting domain‑like protein. A better understanding of the mechanism protein kinase 1 (RIP1) was the first signaling molecule of necroptosis may be useful in the development of novel drugs identified in the necrosome (3). RIP1 and RIP3 interact for necroptosis‑related diseases.
    [Show full text]
  • Dectin-1-Induced RIPK1 and RIPK3 Activation Protects Host Against Candida Albicans Infection
    Cell Death & Differentiation (2019) 26:2622–2636 https://doi.org/10.1038/s41418-019-0323-8 ARTICLE Dectin-1-induced RIPK1 and RIPK3 activation protects host against Candida albicans infection 1 1 1 1 1 1 1 1 1 Mengtao Cao ● Zhengxi Wu ● Qi Lou ● Wenli Lu ● Jie Zhang ● Qi Li ● Yifan Zhang ● Yikun Yao ● Qun Zhao ● 1 1 1,2 Ming Li ● Haibing Zhang ● Youcun Qian Received: 5 November 2018 / Revised: 5 March 2019 / Accepted: 21 March 2019 / Published online: 3 April 2019 © ADMC Associazione Differenziamento e Morte Cellulare 2019 Abstract Necroptosis is a recently defined type of programmed cell death with the specific signaling cascade of receptor-interacting protein 1 (RIPK1) and RIPK3 complex to activate the executor MLKL. However, the pathophysiological roles of necroptosis are largely unexplored. Here, we report that fungus triggers myeloid cell necroptosis and this type of cell death contributes to host defense against the pathogen infection. Candida albicans as well as its sensor Dectin-1 activation strongly induced necroptosis in myeloid cells through the RIPK1-RIPK3-MLKL cascade. CARD9, a key adaptor in Dectin-1 signaling, was identified to bridge the RIPK1 and RIPK3 complex-mediated necroptosis pathway. RIPK1 and fl 1234567890();,: 1234567890();,: RIPK3 also potentiated Dectin-1-induced MLKL-independent in ammatory response. Both the MLKL-dependent and MLKL-independent pathways were required for host defense against C. albicans infection. Thus, our study demonstrates a new type of host defense system against fungal infection. Introduction antifungal drugs used in clinical application and increased drugs resistance, it is of great importance to investigate how Fungal infections severely influence human life quality host defenses against fungal infection to develop new and are common worldwide health problem.
    [Show full text]
  • Necroptosis in Intestinal Inflammation and Cancer
    biomolecules Review Necroptosis in Intestinal Inflammation and Cancer: New Concepts and Therapeutic Perspectives Anna Negroni 1,* , Eleonora Colantoni 2, Salvatore Cucchiara 2 and Laura Stronati 3 1 Division of Health Protection Technologies, ENEA, 00123 Rome, Italy 2 Maternal Infantile and Urological Sciences Department, Sapienza, University of Rome, 00161 Rome, Italy; [email protected] (E.C.); [email protected] (S.C.) 3 Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-06-3048-3623 Received: 3 September 2020; Accepted: 8 October 2020; Published: 10 October 2020 Abstract: Necroptosis is a caspases-independent programmed cell death displaying intermediate features between necrosis and apoptosis. Albeit some physiological roles during embryonic development such tissue homeostasis and innate immune response are documented, necroptosis is mainly considered a pro-inflammatory cell death. Key actors of necroptosis are the receptor-interacting-protein-kinases, RIPK1 and RIPK3, and their target, the mixed-lineage-kinase-domain-like protein, MLKL. The intestinal epithelium has one of the highest rates of cellular turnover in a process that is tightly regulated. Altered necroptosis at the intestinal epithelium leads to uncontrolled microbial translocation and deleterious inflammation. Indeed, necroptosis plays a role in many disease conditions and inhibiting necroptosis is currently considered a promising therapeutic strategy. In this review, we focus on the molecular mechanisms of necroptosis as well as its involvement in human diseases. We also discuss the present developing therapies that target necroptosis machinery. Keywords: programmed cell death; inflammation; cancer; intestinal diseases; inhibitors 1. Introduction Cell death is crucial during the development and maintenance of tissue homeostasis in multicellular organisms.
    [Show full text]
  • Die Another Way – Non-Apoptotic Mechanisms of Cell Death
    ß 2014. Published by The Company of Biologists Ltd | Journal of Cell Science (2014) 127, 2135–2144 doi:10.1242/jcs.093575 COMMENTARY Die another way – non-apoptotic mechanisms of cell death Stephen W. G. Tait1,*, Gabriel Ichim1 and Douglas R. Green2,* ABSTRACT apoptosis-resistant cancer cells. In this Commentary, we discuss major forms of non-apoptotic programmed cell death, how they Regulated, programmed cell death is crucial for all multicellular intersect with one another and their occurrence and roles in vivo, organisms. Cell death is essential in many processes, including and we outline outstanding questions. Following this, we ask tissue sculpting during embryogenesis, development of the immune whether it really matter how a cell dies. Specifically, we focus on system and destruction of damaged cells. The best-studied form of how the mode of cell death impacts on immunity and programmed cell death is apoptosis, a process that requires inflammation. activation of caspase proteases. Recently it has been appreciated that various non-apoptotic forms of cell death also exist, such as Necroptosis necroptosis and pyroptosis. These non-apoptotic cell death Various stimuli can engage a non-apoptotic form of cell death called modalities can be either triggered independently of apoptosis or necroptosis (Degterev et al., 2005). Although morphologically are engaged should apoptosis fail to execute. In this Commentary, resembling necrosis, necroptosis differs substantially in that it is a we discuss several regulated non-apoptotic forms of cell death regulated active type of cell death (Galluzzi et al., 2011; Green including necroptosis, autophagic cell death, pyroptosis and et al., 2011).
    [Show full text]
  • Necroptosis: a Novel Manner of Cell Death, Associated with Stroke (Review)
    624 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 41: 624-630, 2018 Necroptosis: A novel manner of cell death, associated with stroke (Review) CHeNglIN lIu*, KAI ZHANg*, Haitao SHeN, XIyANg Yao, QINg SuN and gANg CHeN Department of Neurosurgery, The First Affiliated Hospital of Soochow university, Suzhou, Jiangsu 215006, P.R. China Received December 29, 2015; Accepted October 24, 2017 DOI: 10.3892/ijmm.2017.3279 Abstract. Cell death is indispensable in the physiology, present review, the features, molecular mechanism and iden- pathology, growth, development, senility and death of an tification of necroptosis under pathological conditions are organism. In recent years, the identification of a highly regu- discussed, with particular emphasis on its association with lated form of necrosis, known as necroptosis, has challenged stroke. the traditional concept of necrosis and apoptosis, which are two major modes of cell death. This novel manner of cell death is similar in form to necrosis in terms of morphological Contents features, and it can also be regulated in a caspase‑independent manner. Therefore, necroptosis can be understood initially 1. Introduction as a combination of necrosis and apoptosis. The mechanism 2. Cell death of its regulation, induction and inhibition is complicated, 3. Mechanisms of necroptosis and the TNFα-TNFR1-related and involves a range of molecular expression and regulation. signaling pathway According to the recent literature, necroptosis takes place in 4. Necroptosis in stroke the physiological regulatory processes of an organism and is 5. Necroptosis in other diseases involved in the occurrence, development and prognosis of a 6. Conclusions variety of diseases that have a necrosis phenotype, including neurodegenerative diseases, ischemic disease, hemorrhagic disease, inflammation and viral infectious diseases.
    [Show full text]
  • An IFN-STAT Axis Augments Tissue Damage and Inflammation in A
    ORIGINAL RESEARCH published: 20 May 2021 doi: 10.3389/fmed.2021.644244 An IFN-STAT Axis Augments Tissue Damage and Inflammation in a Mouse Model of Crohn’s Disease Iris Stolzer 1, Anja Dressel 1, Mircea T. Chiriac 1, Markus F. Neurath 1,2 and Claudia Günther 1* 1 Medizinische Klinik 1, Universitäts-Klinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, 2 Deutsches Zentrum Immuntherapie, Universitäts-Klinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany Blocking interferon-function by therapeutic intervention of the JAK-STAT-axis is a novel promising treatment option for inflammatory bowel disease (IBD). Although JAK inhibitors have proven efficacy in patients with active ulcerative colitis (UC), they failed to induce clinical remission in patients with Crohn’s disease (CD). This finding strongly implicates a differential contribution of JAK signaling in both entities. Here, we dissected the contribution of different STAT members downstream of JAK to inflammation and barrier dysfunction in a mouse model of Crohn’s disease like ileitis and colitis (Casp8IEC mice). Deletion of STAT1 in Casp8IEC mice was associated with reduced cell death and a partial rescue of Paneth cell function in the small intestine. Likewise, organoids derived from the small intestine of these mice were less sensitive to cell death triggered by Edited by: IBD-key cytokines such as TNFα or IFNs. Further functional in vitro and in vivo analyses Fernando Gomollón, revealed the impairment of MLKL-mediated necrosis as a result of deficient STAT1 University of Zaragoza, Spain function, which was in turn associated with improved cell survival. However, a decrease Reviewed by: Hiroshi Nakase, in inflammatory cell death was still associated with mild inflammation in the small Sapporo Medical University, Japan intestine.
    [Show full text]
  • Intestinal Epithelial Cells Necroptosis and Its Association with Intestinal Inflammation Anton S
    JOURNAL OF CLINICAL MEDICINE OF KAZAKHSTAN Шолу Мақала / Обзорная Статья / Review Article DOI:10.23950/1812-2892-JCMK-00658 Intestinal epithelial cells necroptosis and its association with intestinal inflammation Anton S. Tkachenko Biochemistry Department, Kharkiv National Medical University, Kharkiv, Ukraine Abstract This review focuses on the role of necroptosis, an alternative mode of cell death, in the pathogenesis of diseases associated with intestinal inflammation whose prevalence has been significantly increased for last decades, which substantiates the relevance of this issue. Necroptosis is a programmed necrosis accompanied by the activation of RIPK3 and MLKL kinases. The article covers molecular mechanisms Received: 2018-12-17 of necroptosis, the role of necroptosis of epithelial intestinal cells in the regulation Accepted: 2019-01-17 of intestinal homeostasis, its potential triggers, as well as features of necroptosis UDC: 616.344-002-092 during the development of intestinal inflammation. The current review suggests that the development and use of medicines that may target necroptosis-associated kinases seem to be a promising therapeutic strategy. J Clin Med Kaz 2019;1(51):12-15 Corresponding Author: Anton S. Tkachenko, Keywords: necroptosis, cell death, intestinal epithelial cells, inflammatory Candidate of Medicine, assistant professor, bowel disease, intestinal inflammation Biochemistry Department, Kharkiv National Medical University, Kharkiv, Ukraine. Tel.: +38-050-109-45-54 E-mail: [email protected] ІШЕК ЭПИТЕЛИОЦИТТЕРІНІҢ НЕКРОПТОЗЫ ЖӘНЕ ОНЫҢ ІШЕКТІК ҚАБЫНУ КЕЗІНДЕГІ РӨЛІ А.С. Ткаченко Биохимия бөлімшесі, Харьков ұлттық медицина университеті, Харьков, Украина ТҰЖЫРЫМДАМА Бұл шолуда некроптоздың – жақында ашылған жасушалық өлім түрінің – ішектің қабынба ауруларының патогенезіндегі рөлі қарастырылады, ол соңғы он жылдықтарда кеңінен таралып отыр және сол себептен зерттеліп отырған мәселе өзекті болып табылады.
    [Show full text]
  • Caspase-8, Receptor-Interacting Protein Kinase 1 (RIPK1), and RIPK3 Regulate Retinoic Acid-Induced Cell Differentiation and Necroptosis
    Cell Death & Differentiation (2020) 27:1539–1553 https://doi.org/10.1038/s41418-019-0434-2 ARTICLE Caspase-8, receptor-interacting protein kinase 1 (RIPK1), and RIPK3 regulate retinoic acid-induced cell differentiation and necroptosis 1,2 1,3 4 3 1,2,4 Masataka Someda ● Shunsuke Kuroki ● Hitoshi Miyachi ● Makoto Tachibana ● Shin Yonehara Received: 1 July 2019 / Revised: 4 October 2019 / Accepted: 4 October 2019 / Published online: 28 October 2019 © The Author(s) 2019. This article is published with open access Abstract Among caspase family members, Caspase-8 is unique, with associated critical activities to induce and suppress death receptor-mediated apoptosis and necroptosis, respectively. Caspase-8 inhibits necroptosis by suppressing the function of receptor-interacting protein kinase 1 (RIPK1 or RIP1) and RIPK3 to activate mixed lineage kinase domain-like (MLKL). Disruption of Caspase-8 expression causes embryonic lethality in mice, which is rescued by depletion of either Ripk3 or Mlkl, indicating that the embryonic lethality is caused by activation of necroptosis. Here, we show that knockdown of Caspase-8 expression in embryoid bodies derived from ES cells markedly enhances retinoic acid (RA)-induced cell differentiation and necroptosis, both of which are dependent on Ripk1 and Ripk3; however, the enhancement of RA-induced 1234567890();,: 1234567890();,: cell differentiation is independent of Mlkl and necrosome formation. RA treatment obviously enhanced the expression of RA-specific target genes having the retinoic acid response element (RARE) in their promoter regions to induce cell differentiation, and induced marked expression of RIPK1, RIPK3, and MLKL to stimulate necroptosis. Caspase-8 knockdown induced RIPK1 and RIPK3 to translocate into the nucleus and to form a complex with RA receptor (RAR), and RAR interacting with RIPK1 and RIPK3 showed much stronger binding activity to RARE than RAR without RIPK1 or RIPK3.
    [Show full text]
  • RIP Kinase 3 in Necroptosis: Does It Take Two Or More to Kill?
    Cell Death and Differentiation (2014) 21, 1505–1507 & 2014 Macmillan Publishers Limited All rights reserved 1350-9047/14 www.nature.com/cdd Editorial RIP kinase 3 in necroptosis: does it take two or more to kill? C Kim1 and M Pasparakis*1 Cell Death and Differentiation (2014) 21, 1505–1507; doi:10.1038/cdd.2014.100 Programmed cell death (PCD) has an important role in ‘Cell Death and Differentiation’ shed some light on this organismal physiology both during embryonic development question. and in adult tissue homeostasis. In addition to the long- In order to study how homodimeric or heterodimeric recognized and well-studied caspase-dependent apoptosis, interactions between RIPK1 and RIPK3 regulate the assem- receptor-interacting protein kinase (RIPK)-mediated necrosis bly and activation of the necrosome, the Han and Oberst labs or necroptosis has been recently identified as a new type of took advantage of chemically induced dimerization systems programmed cell death with key functions during embryogen- allowing to experimentally trigger RIPK1 and RIPK3 homo/ esis, tissue homeostasis and inflammation.1–8 Necroptosis is hetero-dimerization.19,20 They show that RIPK1 could only induced by multiple pathways, such as death receptors of the induce necroptosis upon RHIM-dependent recruitment of tumor necrosis factor receptor (TNFR) superfamily, TRIF- RIPK3, consistent with the notion that RIPK1/RIPK3 associa- dependent Toll-like receptor (TLR) signaling, and type I and tion is critical for necroptosis. However, surprisingly they type II interferon receptors.9 Necroptotic cell death is found that RIPK1/RIPK3 heterodimers were not sufficient to executed by RIPK3-mediated recruitment and phosphoryla- trigger necroptosis unless additional RIPK3 molecules were tion of mixed lineage kinase domain-like protein (MLKL),10–12 recruited to the RIPK1/RIPK3 heterodimer via RHIM-depen- which seems to kill cells by a mechanism dependent on its dent interactions.
    [Show full text]
  • An Incoherent Feedforward Loop Interprets Nfκb/Rela Dynamics to Determine TNF‐Induced Necroptosis Decisions
    Article An incoherent feedforward loop interprets NFκB/ RelA dynamics to determine TNF-induced necroptosis decisions Marie Oliver Metzig1,2, Ying Tang1,2, Simon Mitchell1,2,†, Brooks Taylor1,2, Robert Foreman2,3,4 , Roy Wollman2,3,4 & Alexander Hoffmann1,2,* Abstract inflammatory response genes involved in eliminating pathogens, resolving inflammation and healing (Wallach et al, 1999; Cheng Balancing cell death is essential to maintain healthy tissue home- et al, 2017). However, TNF is also a cell-killing agent (Carswell ostasis and prevent disease. Tumor necrosis factor (TNF) not only et al, 1975; Beutler et al, 1985a) and may trigger apoptotic or activates nuclear factor κB (NFκB), which coordinates the cellular necroptotic cell death programs with distinct pathophysiological response to inflammation, but may also trigger necroptosis, a pro- consequences (Vandenabeele et al, 2010). While apoptotic cells inflammatory form of cell death. Whether TNF-induced NFκB fragment into membrane bound vesicles, which allows their affects the fate decision to undergo TNF-induced necroptosis is removal and resolution of inflammation (Galluzzi et al, 2018), unclear. Live-cell microscopy and model-aided analysis of death necroptotic cells spill damage-associated molecular patterns kinetics identified a molecular circuit that interprets TNF-induced (DAMPs) into the microenvironment, which promotes inflammation NFκB/RelA dynamics to control necroptosis decisions. Inducible (Pasparakis & Vandenabeele, 2015; Wallach et al, 2016). Indeed, expression of TNFAIP3/A20 forms an incoherent feedforward loop necroptosis has been linked to acute and chronic inflammatory to interfere with the RIPK3-containing necrosome complex and diseases (Ito et al, 2016; Newton et al, 2016; Shan et al, 2018), and protect a fraction of cells from transient, but not long-term TNF inhibition may be a promising therapeutic strategy (Degterev et al, exposure.
    [Show full text]
  • Necroptosis in Anti-Viral Inflammation
    Cell Death & Differentiation https://doi.org/10.1038/s41418-018-0172-x REVIEW ARTICLE Necroptosis in anti-viral inflammation 1 1 Himani Nailwal ● Francis Ka-Ming Chan Received: 29 March 2018 / Revised: 8 June 2018 / Accepted: 10 July 2018 © The Author(s) 2018. This article is published with open access Abstract The primary function of the immune system is to protect the host from invading pathogens. In response, microbial pathogens have developed various strategies to evade detection and destruction by the immune system. This tug-of-war between the host and the pathogen is a powerful force that shapes organismal evolution. Regulated cell death (RCD) is a host response that limits the reservoir for intracellular pathogens such as viruses. Since pathogen-specific T cell and B cell responses typically take several days and is therefore slow-developing, RCD of infected cells during the first few days of the infection is critical for organismal survival. This innate immune response not only restricts viral replication, but also serves to promote anti-viral inflammation through cell death-associated release of damage-associated molecular patterns (DAMPs). In recent years, necroptosis has been recognized as an important response against many viruses. The central adaptor for necroptosis, RIPK3, also exerts anti-viral effects through cell death-independent activities such as promoting cytokine gene expression. 1234567890();,: 1234567890();,: Here, we will discuss recent advances on how viruses counteract this host defense mechanism and the effect of necroptosis on the anti-viral inflammatory reaction. Facts Open questions ● Necroptosis is mediated through cellular RHIM domain- ● Is necroptosis a primary driver or secondary form of cell containing proteins, RIPK1, RIPK3, ZBP1, and TRIF.
    [Show full text]
  • TRAF2 Is a Biologically Important Necroptosis Suppressor
    Cell Death and Differentiation (2015) 22, 1846–1857 & 2015 Macmillan Publishers Limited All rights reserved 1350-9047/15 www.nature.com/cdd TRAF2 is a biologically important necroptosis suppressor SL Petersen1, TT Chen1, DA Lawrence1, SA Marsters1, F Gonzalvez1 and A Ashkenazi*,1 Tumor necrosis factor α (TNFα) triggers necroptotic cell death through an intracellular signaling complex containing receptor- interacting protein kinase (RIPK) 1 and RIPK3, called the necrosome. RIPK1 phosphorylates RIPK3, which phosphorylates the pseudokinase mixed lineage kinase-domain-like (MLKL)—driving its oligomerization and membrane-disrupting necroptotic activity. Here, we show that TNF receptor-associated factor 2 (TRAF2)—previously implicated in apoptosis suppression—also inhibits necroptotic signaling by TNFα. TRAF2 disruption in mouse fibroblasts augmented TNFα–driven necrosome formation and RIPK3-MLKL association, promoting necroptosis. TRAF2 constitutively associated with MLKL, whereas TNFα reversed this via cylindromatosis-dependent TRAF2 deubiquitination. Ectopic interaction of TRAF2 and MLKL required the C-terminal portion but not the N-terminal, RING, or CIM region of TRAF2. Induced TRAF2 knockout (KO) in adult mice caused rapid lethality, in conjunction with increased hepatic necrosome assembly. By contrast, TRAF2 KO on a RIPK3 KO background caused delayed mortality, in concert with elevated intestinal caspase-8 protein and activity. Combined injection of TNFR1-Fc, Fas-Fc and DR5-Fc decoys prevented death upon TRAF2 KO. However, Fas-Fc and DR5-Fc were ineffective, whereas TNFR1-Fc and interferon α receptor (IFNAR1)-Fc were partially protective against lethality upon combined TRAF2 and RIPK3 KO. These results identify TRAF2 as an important biological suppressor of necroptosis in vitro and in vivo.
    [Show full text]